Latest: Coromandel International Ltd Q1 FY27 results →All Q4 FY26 results →
CI

Coromandel International Ltd

Q4 FY26Fertilizers & Agrochemicals

Coromandel International Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Price₹1,996
Market cap₹61.6K Cr
P/E33.0
Updated23 Aug 2026
Read4 min read

The short version

Crop Protection business expects 20%-25% revenue growth driven by new registrations, product launches (six new products), and increased active ingredient volumes, especially Mancozeb with new capacities at Dahej and Sarigam. Coromandel expects growth driven by increased manufacturing capacities, especially in active ingredients like Mancozeb (10,000 tons capacity expansion at Dahej and 20,000 tons at Sarigam).

From Coromandel International Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Crop Protection business expects 20%-25% revenue growth driven by new registrations, product launches (six new products), and increased active ingredient volumes, especially Mancozeb with new capacities at Dahej and Sarigam.
  • Formulation business growth projected at 14%-20%, with niche and bio pesticide products gaining traction.
  • Nano DAP segment shows strong growth, with 60% volume expansion and 50% market share.
  • Export volumes expected to rebound after Q4 slowdown; Latin American market inventory issues seem resolved.
  • Fertilizer volumes normalized, with record production and expanded unique grades at 35%.
  • Retail business targets 30% growth by adding new stores and leveraging e-commerce and drone services.

2 more points from Coromandel International Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Coromandel International Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • Dhaksha facility expansion: Moving to a larger facility expected to be ready by May 2026, aiming to enhance drone production and execution of defense orders.
  • Strengthening R&D: Plan to introduce new products in the next 6-9 months to capitalize on prior investments.
  • Dahej plant: Expanded capacity by 10,000 tons of Mancozeb with payback less than one year; an additional 20,000-ton expansion underway at Sarigam expected by mid-2026.
  • Technical MAP and seaweed granulation capacities are being set up in the specialty nutrient business to generate revenue in coming years.

2 more points from Coromandel International Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

Guidance-ranked
1Anya Polytech &
Rev 2Mar 1
2Dharmaj Crop
Rev 2Mar 2
3
Rev 2Mar 3
4
Rev 2Mar 3
5
Rev 3Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Coromandel International Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

  • Dhaksha, Coromandel International's defense-related venture, is currently in a recovery mode with ongoing progress.
  • The first order execution for Dhaksha is expected during the current year, which will boost confidence for repeat orders across various defense segments.
  • The company is expanding Dhaksha’s facility to a larger location, expected to be ready by May.

2 more points from Coromandel International Ltd's call on order book

Create a free account to keep reading this call

Coromandel International Ltd — Quarterly revenue & net profit

Revenue Net profit
Dec 2024Q3 FY25
Mar 2025Q4 FY25
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26

Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹6.0K Cr, net profit ₹115 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Fertilizers & Agrochemicals this season

  • Rama Phosphates Ltd (Q4 FY26)

    Revenue grew by 20% year-on-year (Page 8). Key investor presentation takeaways from Rama Phosphates's Q4 FY26 investor presentation — and how it ranks against s

  • Khaitan Chemicals & Fertilizers Ltd (Q4 FY26)

    Q4-FY26 Operational Revenue: INR 1,930 million, up 20.1% YoY (from INR 1,607 million in Q4-FY25). Key investor presentation takeaways from Khaitan Chemical's Q4

  • Dhansa Labs Ltd (Q4 FY26)

    120-140 crores in additional annual revenue upon stabilization, with initial revenue of around Rs. Key concall takeaways from Dhansa Labs's Q4 FY26 earnings…

  • Advance Agrolife Ltd (Q4 FY26)

    Q4 FY26 total revenue: ₹1,259.07 million, up 40% YoY (Page 24). Key concall takeaways from Advance Agrolife Ltd's Q4 FY26 earnings call — and how it ranks…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Coromandel International Ltd and 15K+ more earnings calls,
for less than your morning chai

a day

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Coromandel International Ltd Q4 FY26 results?

Crop Protection business expects 20%-25% revenue growth driven by new registrations, product launches (six new products), and increased active ingredient volumes, especially Mancozeb with new capacities at Dahej and Sarigam. Coromandel expects growth driven by increased manufacturing capacities, especially in active ingredients like Mancozeb (10,000 tons capacity expansion at Dahej and 20,000 tons at Sarigam).

What is Coromandel International Ltd share price analysis?

Coromandel International Ltd currently shows a neutral. The stock trades at a P/E of 33.0 with a market cap of ₹61,552 Cr. Investors should review the full earnings analysis for detailed insights.

Is Coromandel International Ltd planning capital expenditure?

Dhaksha facility expansion: Moving to a larger facility expected to be ready by May 2026, aiming to enhance drone production and execution of defense orders.

Keep Coromandel International Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.